ResearchProjects

Metropolitan Trajectories of HIV Epidemics, Drug Use, and Responses in US Key Populations
Funded by: National Institute on Drug Abuse
Project dates: June 2014 - March 2019
Principal Investigator: Friedman, Samuel
Principal Investigator: Cooper H
Principal Investigator: Stall R
PROJECT DESCRIPTION

For over 30 years, almost all studies of HIV/AIDS epidemics and programs have focused on one key population (e.g., injectors, men who have sex with men, or heterosexuals) in isolation from other key populations. This approach has significantly limited scientific understanding of the fundamental dynamics of HIV/AIDS epidemics. Research analyses have suggested that HIV/AIDS epidemics and programs in one key population may affect epidemics and programs in other key populations. Likewise, programs targeting one key population may affect epidemics in other key populations. The current study will pioneer a novel line of high-impact epidemiologic, programmatic, and policy research on whether and how HIV/AIDS epidemics and programs affect one another across three key populations (i.e., men who have sex with men (MSM), people who inject drugs (PWID), and heterosexuals) in the US. Findings will open up new arenas for intervention, including interventions that seek to prevent epidemics in one key population from affecting epidemics in other key populations, and that maximize positive effects of interventions across key populations.

Abstract NIH RePORTER
Related Publications
Ibragimov U, Beane S, Adimora AA, Friedman SR, Williams L, Tempalski B, Stall R, Wingood G, Hall HI, Johnson AS, Cooper HLF (2018).
Relationship of racial residential segregation to newly diagnosed cases of HIV among Black heterosexuals in US metropolitan areas, 2008-2015
Journal of Urban Health [Epub 2018 Sep 4]. doi: 10.1007/s11524-018-0303-1.

Tempalski B, Cleland CM, Williams LD, Cooper HLF, Friedman SR (2018).
Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007
Substance Abuse Treatment, Prevention and Policy, 13, 28. doi: 10.1186/s13011-018-0165-2. PMCID: PMC6085615.

Tempalski B, Cooper HLF, Kelley ME, Linton SL, Wolfe ME, Chen YT, Ross Z, Des Jarlais DC, Friedman SR, Williams LD, Semaan S, DiNenno E, Wejnert C, Broz D, Paz-Bailey G (2018).
Identifying which place characteristics are associated with the odds of recent HIV testing in a large sample of people who inject drugs in 19 US metropolitan areas
AIDS and Behavior [Epub 2018 Jul 3]. doi: 10.1007/s10461-018-2217-z.

Friedman SR, Tempalski B, Brady JE, West BS, Pouget ER, Williams LD, Des Jarlais DC, Cooper HL (2016).
Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research
International Journal of Drug Policy, 32, 11-16. doi: 10.1016/j.drugpo.2016.03.003. PMCID: PMC5344442.

Cooper HL, West B, Linton S, Hunter-Jones J, Zlotorzynska M, Stall R, Wolfe ME, Williams L, Hall HI, Cleland C, Tempalski B, Friedman SR (2016).
Contextual predictors of injection drug use among Black adolescents and adults in US metropolitan areas, 1993-2007
American Journal of Public Health, 106 (3), 517-526. doi: 10.2105/AJPH.2015.302911. PMCID: PMC4815709.

Friedman SR, Rossi D (2015).
Some musings about big events and the past and future of drug use and of HIV and other epidemics
Substance Use and Misuse, 50 (7), 899-902. doi: 10.3109/10826084.2015.1018752. PMCID: PMC4792193.